Carolina Infusion recalls

Carolina Infusion LLC recalled Tri-MIX (a compounded injection containing papaverine, phentolamine, and alprostadil) due to concerns that the product may not be sterile. The issue stems from the use of bacteriostatic water in the formulation and potential problems with processing equipment.

Carolina Infusion LLC is recalling Tri-MIX (PAPAV/PHENTO/ALPROS) injectable medication due to concerns that the product may not be sterile. The issue stems from the use of bacteriostatic water in formulation and potential contamination from processing equipment used during compounding.

Carolina Infusion, LLC has recalled compounded tirzepatide/cyanocobalamin injectable syringes due to concerns that the product may not be sterile. The issue stems from the use of bacteriostatic water in formulation and potential contamination risks related to processing equipment. The affected syringes were distributed nationwide.

Carolina Infusion, LLC has recalled tirzepatide/cyanocobalamin injectable syringes due to concerns that the sterility of the product cannot be assured. The issue is related to the use of bacteriostatic water in the formulation and processing equipment used to prepare the compounded medication. Three specific lots distributed nationwide are affected.

Carolina Infusion, LLC has recalled compounded tirzepatide/cyanocobalamin injectable syringes due to lack of assurance of sterility. The issue stems from the use of bacteriostatic water in formulation and concerns with processing equipment. The affected product was distributed nationwide in patient-specific single-use syringes.

Carolina Infusion, LLC is recalling tirzepatide/cyanocobalamin injectable medication due to lack of assurance of sterility. The issue relates to the formulation process using bacteriostatic water and processing equipment used to compound the product. The affected medication was distributed nationwide in patient-specific syringes.

Carolina Infusion LLC is recalling compounded semaglutide/cyanocobalamin injectable syringes due to lack of assurance of sterility. The issue stems from the use of bacteriostatic water in formulation and concerns about processing equipment. The recall affects five specific lots distributed nationwide.

Carolina Infusion LLC is recalling Tri-MIX (papaverine/phentolamine/alprostadil) injectable solution due to concerns that processing equipment may not have maintained proper sterility standards during manufacturing. The product is a compounded injectable medication packaged in single-use syringes for individual patient prescriptions.

Carolina Infusion recalled Tri-MIX (a compounded injectable medication) because processing equipment used to make it may not have been properly sterilized. The affected product is packaged in single-use syringes and was distributed nationwide. This means the medication may not be sterile and could pose a health risk if used.

Carolina Infusion, LLC is recalling Tri-MIX (papaverine/phentolamine/alprostadil) injectable solution due to a sterility assurance issue related to processing equipment used during compounding. The product is dispensed in single-use syringes and was distributed nationwide. No injuries have been reported to date.

Carolina Infusion, LLC is recalling Tri-MIX (papaverine/phentolamine/alprostadil) injectable medication due to a lack of assurance of sterility. The issue is related to processing equipment used to compound the product. The affected medication was packaged in single-use dosage syringes and distributed nationwide.

Carolina Infusion, LLC is recalling QUAD-MIX injectable medication (a compounded injection containing papaverine, phentolamine, alprostadil, and tropicamide) due to concerns about sterility. The issue stems from processing equipment used to prepare the product. The affected lot is 08032026@24, with a Beyond Use Date of 09/17/2026.

Carolina Infusion LLC is recalling Sermorelin Acetate 1 mg/mL injectable due to concerns that the product may not be sterile. The issue relates to the formulation process and equipment used to prepare the medication.

Carolina Infusion, LLC is recalling semaglutide/cyanocobalamin injectable medication packaged in single-use syringes due to concerns that the product may not be sterile. The issue stems from the use of bacteriostatic water in formulation and potential problems with processing equipment used to compound the product.

Carolina Infusion LLC is recalling semaglutide 3 mg/mL injectable syringes due to concerns about sterility assurance. The issue stems from the formulation process using bacteriostatic water and processing equipment used to prepare the compounded product.

Carolina Infusion LLC is recalling tirzepatide 26 mg/mL injectable syringes due to concerns that the product may not be sterile. The issue is related to the use of bacteriostatic water in formulation and processing equipment used to compound the product. The recall affects specific lot numbers distributed nationwide.